Biotechnology
Found 92 companies.
🏢 Empatica
👥 51-100💰 $25,949,980 Series B over 2 years agoArtificial Intelligence (AI)BiotechnologyMachine LearningWearablesHealth Care💼 Private Company
Website LinkedIn Email Facebook Twitter

Empatica is a rapidly growing digital healthcare company pioneering AI-driven continuous patient monitoring and digital biomarker development. We create medical-grade smartwatches and a comprehensive software platform that enables remote health monitoring for various conditions, delivering clinical-quality data. Our work significantly impacts healthcare research, treatment, and patient outcomes, placing us at the forefront of the evolving digital health landscape. We leverage a robust tech stack, including iOS/Android compatibility, Google Tag Manager, Google Analytics, and more, fostering an agile and innovative engineering culture. Our collaborative environment values diversity and inclusion, supporting employee growth through flexible work arrangements, remote work options, and a generous benefits package. We’re a well-funded company with a clear path toward continued expansion, offering exceptional career opportunities in a field poised for significant disruption. We're passionate about making a positive impact on global health, and we welcome passionate individuals to join our team. Empatica's engineering team works in a fast-paced, collaborative environment where new technologies are constantly explored and integrated. We prioritize agile development methods and data-driven decision-making. Our current technology focus includes AI algorithms for biomarker analysis, mobile app development for both iOS and Android, secure cloud infrastructure, and medical-grade wearable device integration. This diverse and challenging environment provides ample growth opportunities, making Empatica a compelling choice for tech professionals seeking meaningful and impactful work. Empatica embraces a diverse and inclusive culture that reflects our global team. We offer flexible working hours, generous benefits, including free healthy lunch and a personal learning budget, and opportunities to engage in unique experiences such as our annual beach retreat. Our commitment to employee well-being extends to mental health support and wellness programs. As a company, we value open communication, respect, and teamwork. We strongly believe that these values, coupled with our commitment to providing industry-leading products and services, cultivate a rewarding and productive work environment for our employees. With multiple successful funding rounds totaling over $33M, Empatica's trajectory is firmly set on expanding its platform's capabilities and market reach. Our growing team benefits from the excitement of a high-impact company backed by substantial investment, offering employees the chance to own a piece of our success through equity participation and the opportunity to truly influence the future of healthcare.

🏢 Healios
👥 51-100💰 $30,942,365 over 11 years agoBiotechnologyMedicalManufacturingHealth Care📈 Public Company
Website LinkedIn Email

Healios is a leading digital healthcare company revolutionizing neurodevelopmental care. We deliver comprehensive assessments and interventions for autism, ADHD, and other related conditions through a fully digital platform, enabling seamless care from the comfort of home. This innovative approach significantly improves accessibility and patient experience. We are pioneering the world's first digitalization of NHS mental health trust outpatient services, a testament to our commitment to improving mental healthcare worldwide. Our tech stack includes a blend of robust and widely-used technologies, including iPhone/Mobile compatibility, Viewport Meta, Google Tag Manager, Google Analytics, WordPress, DoubleClick.Net, and reCAPTCHA. We maintain a flexible, collaborative environment encouraging innovation and continuous professional development. Our remote-first work model attracts top talent seeking work-life balance and impactful careers. Healios is driven by a mission to bring exceptional healthcare to anyone, anytime, anywhere. We embrace diversity and prioritize both employee well-being and patient outcomes. Our values reflect a commitment to ethical practice, safety, and inclusivity. We're a rapidly growing, well-funded company with significant expansion plans, backed by substantial investment and a strong team of professionals. Founded in 2011, Healios is publicly traded (TYO:4593) and operates with a team of 51-100 employees. Our success is built on a foundation of impactful technology, a supportive culture, and a unwavering commitment to providing exceptional care.

🏢 Ascend Advanced Therapies
👥 101-250💰 $130,574,171 2 months agoBiotechnologyMedicalGenetics💼 Private Company
Website LinkedIn Email

Ascend Advanced Therapies partners with life science innovators to bring cutting-edge gene therapy products to patients. We offer unparalleled collaboration, guiding your products from the bench through clinical trials and beyond. Our expertise spans gene therapy development and commercialization, leveraging a world-class analytical toolkit within our scalable AAV platform. We prioritize scientific innovation, quality, and responsibility, constantly striving to improve yield and quality in each process. Ascend operates in a dynamic and competitive market, positioning itself as a leader in gene therapy manufacturing. Our unique IP and platform assets give us a competitive edge, while our team of industry veterans—a result of recent acquisitions of Freeline Therapeutics and Beacon Therapeutics teams—brings decades of experience. We offer a collaborative and forward-thinking environment, embracing adaptability and continuous improvement. We are committed to serving patients by serving our partners, fostering a culture of mutual trust and support. Our tech stack includes Amazon web services and CRM software (HubSpot mentioned). We utilize various analytical tools (including, but not limited to, Global Data and Zymewire), and our employees benefit from opportunities for professional development and advancement. With over 120 employees across multiple locations, including Alachua, FL and Rockville, MD, we are rapidly expanding and shaping the future of accessible life-saving therapies. Ascend is a privately held company, recently securing significant funding. Our growth trajectory is robust, driven by a strong pipeline of promising gene therapy projects and a commitment to innovation and excellence.

🏢 PicnicHealth
👥 51-100💰 $60,000,000 Series C over 2 years agoBiotechnologyBig DataMedicalAnalyticsData VisualizationHealth Care💼 Private Company
Website LinkedIn Email Facebook Twitter

PicnicHealth simplifies access to medical records and fuels medical research using cutting-edge technology. We provide patients with a secure online dashboard to view their complete medical history from any US healthcare provider. This data, when anonymized and consented, empowers life sciences research, enabling breakthroughs in care. We are uniquely positioned at the intersection of patient empowerment and groundbreaking research, offering a significant impact on healthcare. Our team employs a robust tech stack, including React, Node.js, Python, GraphQL, PostgreSQL, Redis, and cloud infrastructure (GCP and Kubernetes). We foster a collaborative, remote-first engineering culture that values innovation and continuous improvement. Our engineers work across the full stack, shipping code frequently and taking ownership of projects from inception to deployment. We prioritize building well-architected systems, and we support our team through mentorship opportunities and a focus on professional development. PicnicHealth's mission is to redefine healthcare by leveraging data responsibly. We're an award-winning company with a proven track record of success, having partnered with top biopharma companies and secured over $100 million in venture funding. Our growth trajectory is strong, and we're looking for talented individuals to join our team and contribute to our ongoing success. We offer a remote-first environment with opportunities for in-person collaboration, excellent compensation and benefits, and the satisfaction of making a tangible difference in healthcare. We value diversity and inclusion and are committed to creating a supportive work environment where everyone feels valued and respected. Join a team passionate about transforming healthcare through technology and impactful research.

🏢 Invivyd
👥 101-250💰 $336,000,000 Series C almost 4 years ago🫂 Last layoff 9 months agoPharmaceuticalBiotechnologyTherapeutics📈 Public Company
Website LinkedIn Email Facebook Twitter

Invivyd is a commercial-stage biopharmaceutical company pioneering antibody-based therapies to combat serious viral infectious diseases. Our focus is on rapidly developing and delivering preventative treatments, starting with SARS-CoV-2, to protect vulnerable populations. We're making a significant impact on public health by leveraging our proprietary INVYMAB™ platform, which combines advanced viral surveillance, predictive modeling, and antibody engineering for efficient monoclonal antibody (mAb) generation. This innovative approach allows us to respond quickly to emerging viral threats. Invivyd operates with a robust technological foundation, employing a tech stack that includes SPF, DNSSEC, HSTS, Amazon Web Services (including the Virginia Region), and Microsoft Exchange Online, among others. We foster a collaborative and innovative engineering culture where we encourage bold thinking, targeted risk-taking, and a willingness to embrace change. Our commitment is to fostering an environment where employees can thrive and contribute to our mission. Driven by a passion to save lives, Invivyd values ingenuity, collaboration, and a relentless pursuit of scientific excellence. We're a team of dedicated individuals committed to making a tangible difference in the fight against viral infections. We are a NASDAQ-listed company with significant funding and a clear growth trajectory. Invivyd offers employees a chance to be part of a rapidly growing, mission-driven organization with significant opportunities for career advancement. We offer remote work opportunities, allowing for flexibility and work-life balance. Our commitment to diversity and inclusion is reflected in our inclusive and welcoming environment. Join Invivyd and become part of a team that is reshaping the future of viral infectious disease prevention.

🏢 Genezen
👥 51-100💰 $18,500,000 about 1 year agoBiotechnologyManufacturingGenetics💼 Private Company
Website LinkedIn Email Twitter

Genezen is a leading contract development and manufacturing organization (CDMO) specializing in gene therapy. We provide comprehensive services, including process development, GMP viral vector production, transduced cell manufacturing, and analytical testing, supporting the entire gene and cell therapy product lifecycle from research to commercialization. Our expertise lies in delivering high-quality, compliant solutions for our clients' critical programs, accelerating their path to bringing life-changing therapies to patients. Genezen leverages a robust technological foundation, including a sophisticated tech stack encompassing Amazon Web Services, Cloudflare's CDN and security suite (including Bot Manager), and DNSSEC for enhanced security and reliability. We're a company of innovators committed to collaborative problem-solving within a fast-paced environment, fostering a culture that empowers employees to excel. Our dedication to scientific excellence and urgency in bringing treatments to patients guides our operations and informs our commitment to continuous improvement. With over 50 employees and a recent Series Unknown funding round in November 2023, Genezen is experiencing rapid growth and actively seeking talented individuals to contribute to our mission. Our commitment to employees includes competitive benefits, including a 401(k) match, paid time off, and comprehensive health plans. We offer both remote and on-site opportunities at our facilities in Fishers, Indiana (near Indianapolis) and Lexington, Massachusetts (near Boston). Genezen is a dynamic organization working at the forefront of cutting-edge gene therapy manufacturing. We offer a collaborative and rewarding work environment for individuals passionate about making a difference in the lives of patients.

🏢 Amylyx Pharmaceuticals
👥 251-500💰 $246,300,000 Post-IPO Equity over 2 years ago🫂 Last layoff 10 months agoPharmaceuticalBiotechnologyMedicalNeuroscience📈 Public Company
Website LinkedIn Twitter

Amylyx Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to developing innovative treatments for neurodegenerative diseases like ALS, PSP, and Wolfram syndrome. Our flagship product, RELYVRIO (ALBRIOZA in Canada), represents a significant advancement in ALS treatment, and we're actively pursuing further advancements through our pipeline. We're making a tangible impact on patients' lives by addressing the root causes of these debilitating conditions. Our approach is driven by scientific rigor and a commitment to collaborative innovation. Amylyx leverages a robust technology stack that includes tools like Google Tag Manager, Google Analytics, and a Content Delivery Network (CDN) to ensure efficient data management and seamless product delivery. We foster a dynamic and collaborative engineering culture, combining cutting-edge technologies with a focus on data-driven decision-making. Our values of Audacious, Curious, Authentic, Engaging and Accountable guide our work and inform our interactions – leading to a supportive and innovative environment. We offer a variety of roles including remote-friendly options, providing the flexibility to contribute meaningfully to our mission from diverse locations. Amylyx is a rapidly growing company, having recently undergone a successful IPO, showing our commitment to continuing to deliver impactful treatments for patients. We encourage collaborative, unconventionally-thinking individuals to join our team and help us make a difference in the fight against neurodegenerative diseases. Our company is committed to creating a positive and inclusive workplace for everyone. We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.

🏢 Entrada Therapeutics
👥 101-250💰 $100,000,000 Post-IPO Equity 7 months agoBiotechnologyEmergency MedicineMedicalHealth CareGenetics💼 Private Company
Website LinkedIn Email

Entrada Therapeutics is a clinical-stage biopharmaceutical company pioneering a novel approach to treating devastating diseases. We develop Endosomal Escape Vehicle (EEV™) therapeutics, designed for efficient intracellular delivery of proteins, peptides, and nucleic acids, overcoming limitations of traditional large and small molecule therapies. This innovative technology allows us to target previously inaccessible intracellular pathways, advancing a robust portfolio of RNA-, antibody-, and enzyme-based programs for neuromuscular, ocular, metabolic, and immunological diseases. Our lead oligonucleotide programs are in development for Duchenne muscular dystrophy, and we've partnered on a clinical-stage program for myotonic dystrophy type 1. Entrada operates with a strong tech foundation, utilizing technologies such as Drupal 10, Akamai EdgeWorkers, and BunnyCDN Header for our web infrastructure and various other technologies for streamlining internal processes. Our engineering culture fosters collaboration and innovation, valuing a balance between cutting-edge technology and patient-focused results. We pride ourselves on our values of Humanity, Tenacity, Creativity, Collaboration, and Curiosity – these principles guide our work and interactions. We're a dynamic team of experts in therapeutic development and rare diseases, currently employing 101-250 people and headquartered in Boston, MA. With significant funding secured and a growing pipeline of promising therapies, Entrada is poised for continued growth and expansion. We offer a variety of remote work opportunities and employee benefits designed to support a positive work-life balance. Entrada is an equal opportunity employer committed to fostering a diverse and inclusive workplace. We encourage candidates from all backgrounds to apply.

🏢 Roivant Sciences
👥 501-1000💰 $230,000,000 Post-IPO Equity almost 2 years ago🫂 Last layoff about 2 years agoPharmaceuticalBiotechnologyBiopharmaProduct ResearchHealth Care📈 Public Company
Website LinkedIn Email Facebook Twitter

Roivant Sciences is a biopharmaceutical company accelerating the development of promising late-stage drug candidates. We achieve this by building and supporting nimble, entrepreneurial biotech companies (Vants), leveraging a unique approach to talent acquisition, incentive alignment, and technology deployment. Our focus is on reducing the time and cost of bringing new medicines to market, ultimately improving patient lives and benefiting the healthcare system. We've successfully launched VTAMA®, achieved multiple FDA approvals, and secured significant global partnerships. This rapid growth has been fueled by strategic in-licensing, acquisitions, and a commitment to innovation. Our tech-enabled approach is central to our success. We utilize a robust technology stack including iPhone/Mobile compatibility, Google Tag Manager, Google Analytics, and a Content Delivery Network (CDN), ensuring efficient data management and streamlined operations. We foster a dynamic, collaborative environment, embracing both remote and in-person work models. Our engineering culture values agility, innovation, and a data-driven approach to problem-solving. Roivant's mission is to dramatically improve healthcare outcomes. We are a large company, currently employing between 501 and 1000 people, and we strive to create a rewarding and impactful workplace. We value both individual achievement and collaborative teamwork. We offer a range of exciting opportunities across multiple therapeutic areas, in both clinical development and tech-focused operations. Our significant funding and consistent success position us for continued growth and leadership in the biopharmaceutical industry. Roivant prioritizes diversity, equity, and inclusion. We are proud of our diverse workforce and offer a supportive and inclusive environment where every employee's contributions are valued. We embrace remote work, offering flexibility and empowering employees to perform at their best, regardless of location. With offices globally, we're a dynamic organization continually seeking talented and passionate individuals to join our mission.

🏢 Biomapas
👥 101-250Biotechnology💼 Private Company
Website LinkedIn Email Twitter

Biomapas: Shaping the Future of Life Sciences Biomapas is a leading full-service Contract Research Organization (CRO) providing comprehensive solutions to the global life sciences industry. We specialize in clinical research, regulatory affairs, pharmacovigilance, and medical writing, supporting biopharmaceutical, medical device, cosmetics, and food supplement companies across their entire product lifecycle. Our expertise spans diverse therapeutic areas and key geographical regions, including Europe, CIS, MENA, and LATAM. We distinguish ourselves through a commitment to tailored solutions and a hands-on approach, addressing complex challenges efficiently and cost-effectively. Our team of experienced professionals works collaboratively with clients, becoming an integral part of their journey from early development to commercial success. This collaborative approach, combined with our global reach and deep understanding of regulatory landscapes, offers a significant competitive advantage. Biomapas leverages a robust technology stack, including Apache 2.4, Ubuntu, Amazon SSL, and Debian, to ensure efficient and secure operations. Our engineering culture prioritizes innovation and efficiency, fostering a dynamic and supportive work environment. While we don't currently have open vacancies, we are always seeking exceptional talent who share our passion for advancing the life sciences industry. Established in 2001, Biomapas employs 101-250 professionals and enjoys a strong market presence. We are committed to growth and innovation and actively seek opportunities to expand our capabilities and global reach. Join us in shaping the future of life sciences.

Shown 10 out of 92